Publications by authors named "Harue Tada"

Claim this Profile
L
Long-term outcome of PDT for local failure after CRT or RT for oesophageal cancer.
Takahiro Horimatsu, Tomonori Yano, Yoshinobu Yamamoto, Hiromi Kataoka, Yohei Yabuuchi, Harue Tada

J Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc analysis of a randomized placebo-controlled trial suggests potential visual benefits of branched-chain amino acids in retinitis pigmentosa.
Tomoko Hasegawa, Hanako Ohashi Ikeda, Hiroyasu Abe, Yoko Amino, Takayuki Nakagawa, Harue Tada

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Response: The Future of Retinitis Pigmentosa Research: Unlocking the Potential of Branched-Chain Amino Acid Therapy.
Hanako O Ikeda, Tomoko Hasegawa, Hiroyasu Abe, Yoko Amino, Takayuki Nakagawa, Harue Tada

Transl Vis Sci Technol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Branched Chain Amino Acids on Retinitis Pigmentosa: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Hanako O Ikeda, Tomoko Hasegawa, Hiroyasu Abe, Yoko Amino, Takayuki Nakagawa, Harue Tada

Transl Vis Sci Technol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-hydrostatic pressure device for nevus tissue inactivation and dermal regeneration for reconstructing skin defects after giant congenital melanocytic nevus excision: a clinical trial.
Hiroki Yamanaka, Eiichi Sawaragi, Takashi Nakano, Yasuhiro Katayama, Tatsuya Ito, Harue Tada

Regen Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.
Naoshi Sugimoto, Junya Kanda, Sou Nakamura, Toshiyuki Kitano, Masakatsu Hishizawa, Tadakazu Kondo, Harue Tada

Blood· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study.
Yukiko Mori, Osamu Kikuchi, Takahiro Horimatsu, Hiroki Hara, Shuichi Hironaka, Harue Tada

Esophagus· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.
Shusuke Akamatsu, Naoki Terada, Ryo Takata, Hidefumi Kinoshita, Kimihiro Shimatani, Harue Tada, Tadashi Matsuda

JNCI Cancer Spectr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.
Takashi Nomura, Eriko Sumi, Gyohei Egawa, Saeko Nakajima, Eiko Toichi, Harue Tada

JID Innov· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations.
Takayuki Kondo, Haruhiko Banno, Taro Okunomiya, Yoko Amino, Kayoko Endo, Harue Tada

BMJ Open· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Silk-elastin Sponges in Patients with Chronic Skin Ulcers: A Phase I/II, Single-center, Open-label, Single-arm Clinical Trial.
Kazuo Noda, Katsuya Kawai, Yoshitaka Matsuura, Toshiko Ito-Ihara, Yoko Amino, Harue Tada

Plast Reconstr Surg Glob Open· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial.
Hanako Ohashi Ikeda, Yuki Muraoka, Masayuki Hata, Eriko Sumi, Takafumi Ikeda, Harue Tada

PLoS One· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial.
Takashi Nomura, Eriko Sumi, Gyohei Egawa, Saeko Nakajima, Eiko Toichi, Harue Tada

Trials· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical trial for Kienböck disease by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts: A report of five cases.
Ryosuke Ikeguchi, Tomoki Aoyama, Ryosuke Kakinoki, Michiko Ueda, Yasuaki Kasai, Harue Tada

J Orthop Sci· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between the Lunar Phase and Tail-Lifting Behavior of Lizards () Exposed to an Extremely Low-Frequency Electromagnetic Field.
Tsutomu Nishimura, Harue Tada, Masanori Fukushima

Animals (Basel)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts.
Eriko Sumi, Takashi Nomura, Ryuta Asada, Ryuji Uozumi, Harue Tada

Clin Drug Investig· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer.
Tomoharu Sugie, Eiji Suzuki, Akira Yamauchi, Kazuhiko Yamagami, Norikazu Masuda, Harue Tada

Breast· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer.
Tomonori Yano, Hiroi Kasai, Takahiro Horimatsu, Kenichi Yoshimura, Satoshi Teramukai, Harue Tada

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head.
Yutaka Kuroda, Ryuta Asada, Kazutaka So, Atsushi Yonezawa, Manabu Nankaku, Harue Tada

Int Orthop· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effects of ghrelin on gastrointestinal involvement in patients with systemic sclerosis.
Hiroyuki Ariyasu, Hiroshi Iwakura, Naoichiro Yukawa, Toshinori Murayama, Masayuki Yokode, Harue Tada

Endocr J· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.
Takayuki Nakagawa, Kozo Kumakawa, Shin-ichi Usami, Naohito Hato, Keiji Tabuchi, Harue Tada

BMC Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of zoledronic acid and the association between its efficacy and γδT cells in postmenopausal women with breast cancer treated with preoperative hormonal therapy: a study protocol.
Eriko Sumi, Tomoharu Sugie, Kenichi Yoshimura, Harue Tada, Takafumi Ikeda

J Transl Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts.
Tomoki Aoyama, Koji Goto, Ryosuke Kakinoki, Ryosuke Ikeguchi, Michiko Ueda, Harue Tada

Tissue Eng Part B Rev· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis